• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：低血清25-羟基维生素D（维生素D）水平与新冠病毒易感性、严重程度及死亡率的关联：一项系统评价与荟萃分析

Corrigendum: Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis.

作者信息

Akbar Mohammad Rizki, Wibowo Arief, Pranata Raymond, Setiabudiawan Budi

机构信息

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.

Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia.

出版信息

Front Nutr. 2021 Sep 27;8:754539. doi: 10.3389/fnut.2021.754539. eCollection 2021.

DOI:10.3389/fnut.2021.754539
PMID:34646855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8503747/
Abstract

[This corrects the article DOI: 10.3389/fnut.2021.660420.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fnut.2021.660420。]

相似文献

1
Corrigendum: Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis.勘误：低血清25-羟基维生素D（维生素D）水平与新冠病毒易感性、严重程度及死亡率的关联：一项系统评价与荟萃分析
Front Nutr. 2021 Sep 27;8:754539. doi: 10.3389/fnut.2021.754539. eCollection 2021.
2
Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis.低血清25-羟维生素D（维生素D）水平与COVID-19易感性、严重程度及死亡率相关：一项系统评价与荟萃分析
Front Nutr. 2021 Mar 29;8:660420. doi: 10.3389/fnut.2021.660420. eCollection 2021.
3
Corrigendum: Effects of Vitamin D and K on Interleukin-6 in COVID-19.勘误：维生素D和K对新型冠状病毒肺炎患者白细胞介素-6的影响
Front Nutr. 2022 Mar 8;9:868324. doi: 10.3389/fnut.2022.868324. eCollection 2022.
4
Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.利用遗传变异评估血清维生素 D 浓度对 COVID-19 易感性、严重程度和住院特征的因果效应：一项孟德尔随机化研究。
J Transl Med. 2021 Jul 10;19(1):300. doi: 10.1186/s12967-021-02973-5.
5
Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis.维生素D状态在降低膀胱癌风险中的比较疗效：一项系统评价和网状Meta分析
Nutrition. 2016 May;32(5):515-23. doi: 10.1016/j.nut.2015.10.023. Epub 2015 Dec 19.
6
Corrigendum: Egg Consumption and Stroke Risk: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies.勘误：鸡蛋消费与中风风险：前瞻性研究的系统评价和剂量反应荟萃分析。
Front Nutr. 2020 Nov 23;7:618715. doi: 10.3389/fnut.2020.618715. eCollection 2020.
7
Corrigendum: Vitamin E concentration in breast milk in different periods of lactation: Meta-analysis.勘误：哺乳期不同阶段母乳中维生素E浓度：荟萃分析。
Front Nutr. 2023 Feb 23;9:1099704. doi: 10.3389/fnut.2022.1099704. eCollection 2022.
8
The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality.血清 25-羟维生素 D 水平与 COVID-19 疾病严重程度及其死亡率的关系。
Sci Rep. 2021 Sep 2;11(1):17594. doi: 10.1038/s41598-021-97017-9.
9
The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyvitamin D concentration - a metaanalysis.SARS-CoV-2 感染的严重程度和死亡率与 25-羟维生素 D 浓度的关系——一项荟萃分析。
Adv Respir Med. 2021;89(2):145-157. doi: 10.5603/ARM.a2021.0037.
10
Corrigendum to: The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality".勘误：《维生素D补充剂及25-羟基维生素D水平对心肌梗死风险和死亡率的影响》
J Endocr Soc. 2021 Dec 22;6(1):bvab164. doi: 10.1210/jendso/bvab164. eCollection 2022 Jan 1.

本文引用的文献

1
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.维生素 D 充足，即血清 25-羟维生素 D 水平至少为 30 纳克/毫升，可降低 COVID-19 感染患者发生不良临床结局的风险。
PLoS One. 2020 Sep 25;15(9):e0239799. doi: 10.1371/journal.pone.0239799. eCollection 2020.